Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Medication Index

View All
Acetylcholine Buspirone Imipramine Lofepramine Nortriptyline Vortioxetine
Adapin
Adenosine Pathophysiology of Benzodiazepine Withdrawal Syndrome Protracted Benzodiazepine Withdrawal Syndrome
Alprazolam
Alti-Alprazolam
Amber
Ambien Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Zolpidem
Amitriptyline Adverse Effects of Antidepressants Amitriptyline Antidepressants Dilutions Factors Influencing Development of Withdrawal Effects Nortriptyline Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Receptor occupancy, Solutions and suspensions Stratfiying Risk of Antidepressant Withdrawal Tapering
Amphetamine
Anafranil
Antiepileptic Drugs
Aplenzin
Ativan
Atomoxetine
Baclofen
Bayer
Buprenorphine Desvenlafaxine Duloxetine Paroxetine Venlafaxine
Bupropion Bupropion Factors Influencing Development of Withdrawal Effects Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Receptor occupancy, Stratfiying Risk of Antidepressant Withdrawal
Bupropion HCl
Bupropion Hydrobromide
BuSpar
Buspirone Benzodiazepines Buspirone Clorazepate Management of Complications of Gabapentinoid Discontinuation Other Considerations in Tapering Benzodiazepines and Z-Drugs Receptor occupancy, Solutions and suspensions Tapering Benzodiazepines and Z-Drugs in Practice Tapering Z drugs (benzodiazepine receptor agonists)
Caffeine
Carbamazepine Other Considerations in Tapering Benzodiazepines and Z-Drugs Tapering Benzodiazepines and Z-Drugs in Practice
Carisoprodol
Celexa
Chlordiazepoxide Benzodiazepines Chlordiazepoxide Dilutions Receptor occupancy, Solutions and suspensions Switching to Longer-Acting Benzodiazepines to Taper Tapering Z drugs (benzodiazepine receptor agonists)
Chlordiazepoxide Hydrochloride Chlordiazepoxide Switching to Longer-Acting Benzodiazepines to Taper
Citalopram
Clomipramine Antidepressants Clomipramine Dilutions Doxepin Factors Influencing Development of Withdrawal Effects Solutions and suspensions Stratfiying Risk of Antidepressant Withdrawal Tapering